Fractyl Health (GUTS) announced the appointment of Lara Smith Weber as CFO, effective January 12. Ms. Smith Weber will oversee finance, accounting, and investor relations; and will serve as a key strategic partner to the Company’s executive leadership team and Board of Directors. Most recently, Ms. Smith Weber served as CFO of Inari, where she completed multiple financings, strengthened the company’s capital structure, and built financial systems and processes to support a growing organization. After ten years with the Company, Lisa Davidson has resigned as Fractyl’s CFO effective as of December 31. Davidson will provide consulting services to the Company during this transition.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GUTS:
- Fractyl Health: Advancing Revita and Rejuva Pipelines Toward 2026 Clinical and Regulatory Catalysts Supports Buy Rating
- Fractyl Health Announces Catalyst-Rich Clinical and Funding Outlook
- Fractyl Health outlines strategic outlook for 2026
- Biotech Alert: Searches spiking for these stocks today
- Fractyl Health Calls Tranche A Warrants
